Jeffrey Balduzzi, MD
Allergy · Stockton, CANPI 1235405952
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 316 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations.
Across 316 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$879
- Sanofi$763
- Regeneron Healthcare Solutions, Inc.$740
- Takeda Pharmaceuticals U.S.A., Inc.$578
- GSK$436
- CSL Behring$429
- plus $3K from 25 others
What the payments were for
- Food & beverage$6,42299%
- Education$621%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 22 | $879 |
| Sanofi | 44 | $763 |
| Regeneron Healthcare Solutions, Inc. | 27 | $740 |
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $578 |
| GSK | 36 | $436 |
| CSL Behring | 26 | $429 |
| Amgen | 24 | $423 |
| Grifols USA, LLC | 17 | $378 |
| Pfizer | 17 | $268 |
| Biocryst US Sales Co., LLC | 12 | $230 |
| Kaleo, Inc. | 9 | $214 |
| Novartis | 9 | $187 |
| Optinose US, Inc. | 8 | $159 |
| Genentech USA, Inc. | 4 | $129 |
| Incyte Corporation | 5 | $82 |
| Boehringer Ingelheim | 3 | $77 |
| Chiesi USA, Inc. | 2 | $70 |
| Octapharma USA, Inc. | 3 | $65 |
| Baxter Healthcare | 3 | $58 |
| LEO Pharma Inc. | 2 | $43 |
| Pharming Healthcare, Inc. | 2 | $39 |
| AbbVie | 2 | $34 |
| Electromed, Inc. | 1 | $32 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Organon | 2 | $25 |
| ADMA Biomanufacturing LLC | 2 | $25 |
| Merck | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Covis Pharma GmbH | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,483 in reported general payments places this provider in the 65th percentile of 117 allergy providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Stockton
- Joshua JacobsWalnut Creek$1.5M
- Warner CarrLaguna Niguel$571K
- Bradley ChippsSacramento$571K
- Travis MillerRoseville$273K
- Robert ZeigerSan Diego$162K
- William BergerMission Viejo$76K
- Sandra ChristiansenSan Diego$74K
- Stephen WongHacienda Heights$50K
- Michelle YasharpourBeverly Hills$48K
- Stuart EpsteinBeverly Hills$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.